NCT02602847View on ClinicalTrials.gov

Study of Covalently Closed Circular DNA (cccDNA) in Liver Transplant Patients With B Virus Markers

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Liver Transplantation
Interventions
BIOLOGICAL

cccDNA assay on liver biopsy

cccDNA assay will be performed on liver biopsies at different times : During transplantation : Liver biopsy of explant and graft and virological biology Between M1 to M3 after transplantation : Liver biopsy between 1 to 3 months after transplantation M12 : Liver biopsy 12 months after transplantation

Trial Locations (5)

34295

Hôpital Saint Eloi, Montpellier

38700

CHU Grenoble, La Tronche

69004

Service d'Hépatologie, Hôpital de la Croix-Rousse, Lyon

94804

Hôpital Paul Brousse, Villejuif

06202

CHU de Nice, Nice

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02602847 - Study of Covalently Closed Circular DNA (cccDNA) in Liver Transplant Patients With B Virus Markers | Biotech Hunter | Biotech Hunter